Cargando…

Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia

Refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) is a hematological malignancy that combines features of both a myeloproliferative and myelodysplastic disorder. There have been recent reports of the successful treatment of anemia in 2 patients with RARS-T with...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Gordon, Culligan, Dominic, Vickers, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638575/
https://www.ncbi.nlm.nih.gov/pubmed/23653870
http://dx.doi.org/10.1155/2013/718480
_version_ 1782475844842684416
author Taylor, Gordon
Culligan, Dominic
Vickers, Mark A.
author_facet Taylor, Gordon
Culligan, Dominic
Vickers, Mark A.
author_sort Taylor, Gordon
collection PubMed
description Refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) is a hematological malignancy that combines features of both a myeloproliferative and myelodysplastic disorder. There have been recent reports of the successful treatment of anemia in 2 patients with RARS-T with lenalidomide. Here we report the successful treatment of massive splenomegaly in a patient with a long history of RARS-T resulting in complete resolution of splenomegaly, but with prolonged severe cytopenias. We also report the acquisition of the t(3;12)(q26;p13) translocation previously described in cases of myelodysplasia and the potential for transformation to myelofibrosis.
format Online
Article
Text
id pubmed-3638575
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36385752013-05-07 Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia Taylor, Gordon Culligan, Dominic Vickers, Mark A. Case Rep Hematol Case Report Refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) is a hematological malignancy that combines features of both a myeloproliferative and myelodysplastic disorder. There have been recent reports of the successful treatment of anemia in 2 patients with RARS-T with lenalidomide. Here we report the successful treatment of massive splenomegaly in a patient with a long history of RARS-T resulting in complete resolution of splenomegaly, but with prolonged severe cytopenias. We also report the acquisition of the t(3;12)(q26;p13) translocation previously described in cases of myelodysplasia and the potential for transformation to myelofibrosis. Hindawi Publishing Corporation 2013 2013-04-07 /pmc/articles/PMC3638575/ /pubmed/23653870 http://dx.doi.org/10.1155/2013/718480 Text en Copyright © 2013 Gordon Taylor et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Taylor, Gordon
Culligan, Dominic
Vickers, Mark A.
Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia
title Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia
title_full Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia
title_fullStr Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia
title_full_unstemmed Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia
title_short Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis Complicated by Massive Splenomegaly Treated with Lenalidomide Resulting in Resolution of Splenomegaly but Severe and Prolonged Pancytopenia
title_sort refractory anemia with ring sideroblasts associated with marked thrombocytosis complicated by massive splenomegaly treated with lenalidomide resulting in resolution of splenomegaly but severe and prolonged pancytopenia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638575/
https://www.ncbi.nlm.nih.gov/pubmed/23653870
http://dx.doi.org/10.1155/2013/718480
work_keys_str_mv AT taylorgordon refractoryanemiawithringsideroblastsassociatedwithmarkedthrombocytosiscomplicatedbymassivesplenomegalytreatedwithlenalidomideresultinginresolutionofsplenomegalybutsevereandprolongedpancytopenia
AT culligandominic refractoryanemiawithringsideroblastsassociatedwithmarkedthrombocytosiscomplicatedbymassivesplenomegalytreatedwithlenalidomideresultinginresolutionofsplenomegalybutsevereandprolongedpancytopenia
AT vickersmarka refractoryanemiawithringsideroblastsassociatedwithmarkedthrombocytosiscomplicatedbymassivesplenomegalytreatedwithlenalidomideresultinginresolutionofsplenomegalybutsevereandprolongedpancytopenia